Unique business models reign

 - 
Friday, January 23, 2015

Invacare and ResMed, two of the industry’s few public companies, made the list of most read stories again in 2014, but it was a newcomer, Inogen, that nearly stole the top spot.

Inogen opened for public trading in February of last year and proceeded to wow investors during its subsequent earnings calls with its unique manufacturer-provider business model.

Both Inogen and ResMed say that the worst of competitive bidding is behind the HME industry.

Invacare made the list for its ongoing struggle to lift a consent decree imposed by the U.S. Food and Drug Administration. In 2014, the company also announced a number of changes to its executive leadership. 

Taking the top spot was AssuraMed, which bought a competitor of its Edgepark Medical Supply business unit in 2014. Previously, the company bought Invacare Supply Group. Like Inogen, AssuraMed has raised eyebrows with a unique business model that includes both distributor and provider business lines.

Rounding out the top stories is Brightree, which announced a rebrand in 2014 following numerous acquisitions inside and outside the HME industry.